Vinay K Donempudi1, Juraj Sprung1, Toby N Weingarten2. 1. Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. 2. Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. weingarten.toby@mayo.edu.
Abstract
PURPOSE: Excessive narcotization in pediatric surgical patients has not been well characterized. This report describes the use of postoperative naloxone in pediatric patients. METHODS: Pediatric surgical patients from January 1, 2010, through June 30, 2016, who underwent general anesthesia and received naloxone within 48 h postoperatively were identified and matched 1:1 with controls by age, sex, and procedure. Cases and controls underwent retrospective chart review. RESULTS: Forty-seven patients received naloxone, with a rate of 2.0 (95% CI 1.5-2.7) per 1000 anesthetics. Indications were respiratory depression (n = 19), facilitating extubation (n = 15), and reversing sedation (n = 13), and 44 cases received naloxone in a monitored environment. The median (interquartile range) naloxone dose was 4.0 (2.0-23.5) mcg/kg, and five patients (11%) later required subsequent naloxone treatments. Their characteristics were similar to controls, including opioid medications, except cases that had signs of respiratory depression before naloxone administration. The outcomes were similar, although more cases were admitted to the intensive care unit before naloxone administration. One patient died 13 days postoperatively of unrelated causes. CONCLUSION: Postoperative naloxone administration in pediatric patients is rare. The observation that most administrations occurred in a monitored setting implies that at-risk patients had been appropriately identified and kept under closer surveillance.
PURPOSE: Excessive narcotization in pediatric surgical patients has not been well characterized. This report describes the use of postoperative naloxone in pediatric patients. METHODS: Pediatric surgical patients from January 1, 2010, through June 30, 2016, who underwent general anesthesia and received naloxone within 48 h postoperatively were identified and matched 1:1 with controls by age, sex, and procedure. Cases and controls underwent retrospective chart review. RESULTS: Forty-seven patients received naloxone, with a rate of 2.0 (95% CI 1.5-2.7) per 1000 anesthetics. Indications were respiratory depression (n = 19), facilitating extubation (n = 15), and reversing sedation (n = 13), and 44 cases received naloxone in a monitored environment. The median (interquartile range) naloxone dose was 4.0 (2.0-23.5) mcg/kg, and five patients (11%) later required subsequent naloxone treatments. Their characteristics were similar to controls, including opioid medications, except cases that had signs of respiratory depression before naloxone administration. The outcomes were similar, although more cases were admitted to the intensive care unit before naloxone administration. One patient died 13 days postoperatively of unrelated causes. CONCLUSION: Postoperative naloxone administration in pediatric patients is rare. The observation that most administrations occurred in a monitored setting implies that at-risk patients had been appropriately identified and kept under closer surveillance.
Entities:
Keywords:
Analgesics; General anesthesia; Hypoventilation; Narcotic antagonists; Postoperative complications; Surgery
Authors: Toby N Weingarten; Vitaly Herasevich; Maria C McGlinch; Nicole C Beatty; Erin D Christensen; Susan K Hannifan; Amy E Koenig; Justin Klanke; Xun Zhu; Bhargavi Gali; Darrell R Schroeder; Juraj Sprung Journal: Anesth Analg Date: 2015-08 Impact factor: 5.108
Authors: Lorri A Lee; Robert A Caplan; Linda S Stephens; Karen L Posner; Gregory W Terman; Terri Voepel-Lewis; Karen B Domino Journal: Anesthesiology Date: 2015-03 Impact factor: 7.892
Authors: Eric C Cheon; Hannah L Palac; Kristine H Paik; John Hajduk; Gildasio S De Oliveira; Narasimhan Jagannathan; Santhanam Suresh Journal: Anesthesiology Date: 2016-11 Impact factor: 7.892
Authors: Zhuo Sun; Daniel I Sessler; Jarrod E Dalton; P J Devereaux; Aram Shahinyan; Amanda J Naylor; Matthew T Hutcherson; Patrick S Finnegan; Vikas Tandon; Saeed Darvish-Kazem; Shaan Chugh; Hussain Alzayer; Andrea Kurz Journal: Anesth Analg Date: 2015-09 Impact factor: 6.627